Suppr超能文献

OIP5-AS1沉默通过海绵化miR-135a-5p调控KLF5表达从而保护内皮细胞免受氧化型低密度脂蛋白引发的损伤。

Silencing of OIP5-AS1 Protects Endothelial Cells From ox-LDL-Triggered Injury by Regulating KLF5 Expression via Sponging miR-135a-5p.

作者信息

Zhao Minghu, Yang Yuanyuan, Li Jingchao, Lu Min, Wu Yu

机构信息

Department of Cardiovascular Comprehensive Ward II, Henan Provincial People's Hospital, Zhengzhou, China.

出版信息

Front Cardiovasc Med. 2021 Mar 12;8:596506. doi: 10.3389/fcvm.2021.596506. eCollection 2021.

Abstract

Long non-coding RNAs (lncRNAs) have been implicated in the pathogenesis of atherosclerosis. LncRNA OIP5 antisense RNA 1 (OIP5-AS1) has been found to be associated with the development of atherosclerosis. In this study, we further investigated the molecular basis of OIP5-AS1 in atherosclerosis pathogenesis. Oxidative low-density lipoprotein (ox-LDL) was used to treat human umbilical vein endothelial cells (HUVECs). The levels of OIP5-AS1, miR-135a-5p, and Krüppel-like factor 5 (KLF5) were detected by quantitative real-time polymerase chain reaction (qRT-PCR) or western blot. Cell viability, migration, and apoptosis were evaluated using the Cell Counting Kit-8 (CCK-8), Transwell, and flow cytometry, respectively. The levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and malondialdehyde (MDA) were determined with enzyme-linked immunosorbent assay (ELISA). Targeted interactions among OIP5-AS1, miR-135a-5p, and KLF5 were confirmed by dual-luciferase reporter and RNA immunoprecipitation (RIP) assays. Animal studies were performed to assess the role of OIP5-AS1 in atherosclerosis progression . Our data showed the significant upregulation of OIP5-AS1 in atherosclerosis serum and ox-LDL-stimulated HUVECs. The silencing of OIP5-AS1 protected against ox-LDL-triggered cytotoxicity in HUVECs and diminished lipids secretion in ApoE mice. Moreover, OIP5-AS1 functioned as a molecular sponge of miR-135a-5p, and miR-135a-5p was a functional mediator of OIP5-AS1 in regulating ox-LDL-induced HUVEC injury. KLF5 was a direct target of miR-135a-5p, and the increased expression of miR-135a-5p alleviated ox-LDL-induced cytotoxicity by downregulating KLF5. Furthermore, OIP5-AS1 influenced KLF5 expression through sponging miR-135a-5p. The current work identified that the silencing of OIP5-AS1 protected against ox-LDL-triggered cytotoxicity in HUVECs at least in part by influencing KLF5 expression via acting as a miR-135a-5p sponge.

摘要

长链非编码RNA(lncRNAs)与动脉粥样硬化的发病机制有关。已发现lncRNA OIP5反义RNA 1(OIP5-AS1)与动脉粥样硬化的发展有关。在本研究中,我们进一步探讨了OIP5-AS1在动脉粥样硬化发病机制中的分子基础。使用氧化型低密度脂蛋白(ox-LDL)处理人脐静脉内皮细胞(HUVECs)。通过定量实时聚合酶链反应(qRT-PCR)或蛋白质免疫印迹法检测OIP5-AS1、miR-135a-5p和Krüppel样因子5(KLF5)的水平。分别使用细胞计数试剂盒-8(CCK-8)、Transwell小室和流式细胞术评估细胞活力、迁移和凋亡。用酶联免疫吸附测定(ELISA)法测定白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和丙二醛(MDA)的水平。通过双荧光素酶报告基因和RNA免疫沉淀(RIP)实验证实OIP5-AS1、miR-135a-5p和KLF5之间的靶向相互作用。进行动物实验以评估OIP5-AS1在动脉粥样硬化进展中的作用。我们的数据显示,在动脉粥样硬化血清和ox-LDL刺激的HUVECs中,OIP5-AS显著上调。沉默OIP5-AS1可保护HUVECs免受ox-LDL诱导的细胞毒性,并减少ApoE小鼠的脂质分泌。此外,OIP5-AS1作为miR-135a-5p的分子海绵发挥作用,并且miR-135a-5p是OIP5-AS1调节ox-LDL诱导的HUVEC损伤的功能介质。KLF5是miR-135a-5p的直接靶点,miR-135a-5p表达增加通过下调KLF5减轻ox-LDL诱导的细胞毒性。此外,OIP5-AS1通过吸附miR-135a-5p影响KLF5的表达。目前的研究发现,沉默OIP5-AS1至少部分通过作为miR-135a-5p的海绵影响KLF5的表达,从而保护HUVECs免受ox-LDL诱导的细胞毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bee/7994260/5affe8ec2b1f/fcvm-08-596506-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验